Published in Telemedicine Law Weekly, August 25th, 2007
This trend article about University of Mississippi, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A report, "Inhibition of NF-kappaB-mediated transcription and induction of apoptosis by melampolides and repandolides," is newly published data in Cancer Chemotherapy and Pharmacology. "Nuclear factor-kappaB (NF-kappaB) plays a crucial role in the regulation of inflammatory processes, cell proliferation, and apoptosis. Blocking NF-kappaB signaling may represent a therapeutic strategy in cancer and inflammation therapy," scientists...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.